These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17627323)

  • 1. Characterization of a new gene WX2 in Toxoplasma gondii.
    Wu X; Zhang Q; Tan K; Xie R; Fan J; Shu H; Wang S
    Acta Biochim Biophys Sin (Shanghai); 2007 Jul; 39(7):475-83. PubMed ID: 17627323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
    Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
    BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.
    Lu G; Zhou A; Meng M; Wang L; Han Y; Guo J; Zhou H; Cong H; Zhao Q; Zhu XQ; He S
    BMC Infect Dis; 2014 Dec; 14():3862. PubMed ID: 25527277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.
    Cunha-Júnior JP; Silva DA; Silva NM; Souza MA; Souza GR; Prudencio CR; Pirovani CP; Cezar M Cascardo J; Barbosa BF; Goulart LR; Mineo JR
    Immunobiology; 2010; 215(1):26-37. PubMed ID: 19261354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.
    Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Hassan IA; Xu L; Yan R; Song X; Li X
    BMC Infect Dis; 2015 Oct; 15():448. PubMed ID: 26497908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites.
    Zhang H; Compaore MK; Lee EG; Liao M; Zhang G; Sugimoto C; Fujisaki K; Nishikawa Y; Xuan X
    Mol Biochem Parasitol; 2007 Feb; 151(2):205-12. PubMed ID: 17156863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii.
    Wang L; Lu G; Zhou A; Han Y; Guo J; Zhou H; Cong H; He S
    Parasite Immunol; 2016 Apr; 38(4):209-17. PubMed ID: 26802673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model.
    Chu JQ; Huang S; Ye W; Fan XY; Huang R; Ye SC; Yu CY; Wu WY; Zhou Y; Zhou W; Lee YH; Quan JH
    Korean J Parasitol; 2018 Aug; 56(4):325-334. PubMed ID: 30196664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii.
    Ahmadpour E; Sarvi S; Hashemi Soteh MB; Sharif M; Rahimi MT; Valadan R; Tehrani M; Khalilian A; Montazeri M; Daryani A
    Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28186325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum.
    Yang D; Liu J; Hao P; Wang J; Lei T; Shan D; Liu Q
    Parasitol Res; 2015 Oct; 114(10):3791-9. PubMed ID: 26141436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning of ribosomal P protein in Toxoplasma gondii and the availability to detect antibody against recombinant protein in toxoplasmosis patients.
    Ahn HJ; Kim S; Nam HW
    Korean J Parasitol; 2003 Jun; 41(2):89-96. PubMed ID: 12815319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice.
    Liu Z; Yin L; Li Y; Yuan F; Zhang X; Ma J; Liu H; Wang Y; Zheng K; Cao J
    BMC Immunol; 2016 Oct; 17(1):37. PubMed ID: 27716047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2).
    Chen K; Wang JL; Huang SY; Yang WB; Zhu WN; Zhu XQ
    Parasite; 2017; 24():41. PubMed ID: 29119944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.